XML 61 R40.htm IDEA: XBRL DOCUMENT v3.22.2
Collaboration Agreements And Business Development Activities - Research Collaborations and In-Licensing Arrangements Narrative (Details) - USD ($)
$ in Millions
1 Months Ended
Jun. 30, 2022
Jul. 01, 2022
Collaboration Agreement with BioInvent, Option And License    
Asset Acquisition [Line Items]    
Collaborative arrangement, upfront payment $ 25.0  
Research Collaborations, In-Licensing Arrangements and Other Business Development Activities    
Asset Acquisition [Line Items]    
Collaborative arrangement, maximum aggregate development milestone payments   $ 321.8
Collaborative arrangement, maximum aggregate regulatory milestone payments   453.7
Collaborative arrangement, rights and obligations, maximum aggregate commercial milestone payments   $ 2,070.7